Iron

GlobalData uses 18 years of drug development data to assess drug phase transition and approval likelihood. CR-1202, a gut microbiota modulator by Conaris Research Institute, targets gastrointestinal disorders. Conaris specializes in drug development for inflammatory conditions, offering services from preclinical to GMP development.

The Maternal Fetal Medicine Research Unit at Oregon Health & Science University, known as the Pregnancy Research Group, has been advancing research on pregnant individuals since 2009. Led by Dr. Mónica Rincón, the group ensures ethical, patient-centered studies across various departments, focusing on topics like iron supplementation and rare pregnancy complications. Collaborating with researchers like Dr. Amy Valent and Dr. Nicole Marshall, the group supports multi-site studies and international initiatives, emphasizing patient care and diversity in research to improve maternal and child health outcomes.

The Maternal Fetal Medicine Research Unit at Oregon Health & Science University, known as the Pregnancy Research Group, has been conducting research on pregnant individuals for 15 years. Led by Mónica Rincón, M.D., M.C.R., the group ensures ethical, patient-centered studies across various departments, focusing on topics like diabetes, iron supplementation, and rare complications. They collaborate with researchers like Amy Valent, D.O., and Nicole Marshall, M.D., M.C.R., IBCLC, FACOG, supporting multi-site studies and international initiatives to improve maternal health globally. The group emphasizes patient-centered care and diversity in research to enhance outcomes for mothers and children.

Restless legs syndrome (RLS) involves an urge to move legs, often worsening at rest, affecting sleep and quality of life. The American Academy of Sleep Medicine (AASM) updated guidelines in 2024 recommend iron supplementation for low ferritin levels, alpha-2-delta ligands like gabapentin for treatment, and non-pharmacological options like high-frequency bilateral peroneal nerve stimulation. The guidelines discourage the use of dopamine agonists and levodopa due to long-term complications, emphasizing safer alternatives.

DelveInsight's report on Congestive Heart Failure Market (2020-2034) covers epidemiology, market trends, key companies, and therapies. Market size was ~USD 6,900 million in 2023, expected to grow significantly. Key companies include Novartis, Bayer, and Eli Lilly. Therapies like ENTRESTO and JARDIANCE are highlighted. Market drivers include aging population and disease prevalence, while barriers include generic therapies and diagnostic challenges.

Micro-Tracers' SECURtracers, ethyl cellulose-based particles for drug authentication, await FDA approval as a new excipient. The technology, already ISO 9001:2015 and EXCIPACT accredited, has potential applications beyond pharmaceuticals, including animal feeds. Research collaborations and in vivo studies are ongoing to validate safety and efficacy. Micro-Tracers seeks partnerships with pharmaceutical manufacturers for large-scale trials, offering incentives to be the first to adopt SECURtracers, aiming to combat counterfeit drugs and enhance pharmaceutical security.

Health literacy (HL) interventions in low- and middle-income countries (LMICs) are crucial for improving health outcomes and reducing inequalities. A review of 23 studies identified four HL intervention themes: traditional, art-based, interactive learning, and technology-based. Despite effectiveness in improving knowledge, innovative and technological strategies are underutilized, highlighting the need for future research on sustainable HL interventions.